Generic Drug Alert: FDA Approves Generic Version of Epilepsy Drug Neurontin

Quick generic drug approval bulletin for today. If you have a family member or other loved suffers from epilepsy or pain caused by shingles, the U.S. Food and Drug Administration has given Mylan Pharmaceuticals final approval for gabapentin tablets, a generic version of Pfizer’s prescription drug Neurontin which treats seizures and shingle pain. According to the Epilepsy Foundation, when a person has two or more unprovoked seizures, they are considered to have epilepsy.

Considering a thirty-day supply of brand-name Neurontin is currently running about $190, generic gagapentin tablets could easily be a major savings for the families of many epilepsy patients, so if someone in your family suffers from epilepsy and is on Neurontin, you should ask their doctor if they are an appropriate candidate for the Neurontin generic counterpart.

Does someone in your family use Neurontin? Tell us about it!

Related posts:

1. Generic Drug Alert: FDA Approves Generic Version of Precose for Type 2 Diabetes
2. Generic Drug Alert: FDA Approves Release of Generic Version of Protonix (Pantoprazole)
3. Generic Drug Alert: FDA Approves Generic Version of Lithobid
4. FDA Approves Generic Version of Blood Pressure Drug Plendil (Felodipine)
5. Generic Drug Alert: FDA Approves Generic Version of Lovenox Blood-Thinner